Under the new program, Medicare enrollees will be eligible to receive one of three drugs Foundayo (the new once-a-day tablet), Wegovy, or Zepbound for weight loss specifically
Instead of focusing only on calorie restriction, modern research increasingly explores: Hormonal appetite regulation Gut-brain signalling Insulin sensitivity Energy expenditure Body composition Cardiometabolic risk markers This is why Retatrutide is often mentioned in the same conversation as GLP-1 receptor agonists, GIP/GLP-1 dual agonists, and other next-generation metabolic peptides
The price also depends on the type of peptide prescribed, the dosage, how often it is taken, and whether it comes as injections, capsules, or creams
For individuals exploring ways to improve their metabolic health, the difference often comes down to how platforms deliver personalized care and access to licensed providers
This year it went to 2 scientistsLotte Bjerre Knudsen and Richard DiMarchithe individuals who pushed to get these drugs to treat obesity